 |
 |

Occupation and Risk of ParkinsonismA Multicenter Case-Control Study
Caroline M. Tanner, MD, PhD;
G. Webster Ross, MD;
Sarah A. Jewell, MD, MPH;
Robert A. Hauser, MD;
Joseph Jankovic, MD;
Stewart A. Factor, DO;
Susan Bressman, MD;
Amanda Deligtisch, MD;
Connie Marras, MD, PhD, FRCPC;
Kelly E. Lyons, PhD;
Grace S. Bhudhikanok, PhD;
Diana F. Roucoux, MPH;
Cheryl Meng, MS;
Robert D. Abbott, PhD;
J. William Langston, MD
Arch Neurol. 2009;66(9):1106-1113.
ABSTRACT
Background We examined risk of parkinsonism in occupations (agriculture, education, health care, welding, and mining) and toxicant exposures (solvents and pesticides) putatively associated with parkinsonism.
Objective To investigate occupations, specific job tasks, or exposures and risk of parkinsonism and clinical subtypes.
Design Case-control.
Setting Eight movement disorders centers in North America.
Participants Inclusion criteria were parkinsonism ( 2 cardinal signs), diagnosis within 8 years of recruitment (to minimize survival bias), and ability to participate in detailed telephone interviews. Control subjects were primarily nonblood relatives or acquaintances of patients.
Main Outcome Measures This multicenter case-control study compared lifelong occupational and job task histories to determine associations with parkinsonism and certain clinical subtypes (postural instability and gait difficulty and age at diagnosis 50 years).
Results Findings in 519 cases and 511 controls were analyzed. Work in agriculture, education, health care, or welding was not associated with increased risk of parkinsonism. Unexpected increased risks associated with legal, construction and extraction, or religious occupations were not maintained after adjustment for duration. Risk of parkinsonism increased with pesticide use (odds ratio, 1.90; 95% confidence interval, 1.12-3.21), use of any of 8 pesticides mechanistically associated with experimental parkinsonism (2.20; 1.02-4.75), and use of 2,4-dichlorophenoxyacetic acid (2.59; 1.03-6.48). None of the specific occupations, job tasks, or task-related exposures were associated with younger age at diagnosis ( 50 years). Ever working in business and finance, legal occupations, construction and extraction, or transportation and material moving was associated with postural instability and gait difficulty subtype of parkinsonism. Tobacco use was inversely associated with parkinsonism risk.
Conclusion The association of disease risk with pesticides support a toxicant-induced cause of parkinsonism.
INTRODUCTION
Paralysis agitans was described at the height of the industrial revolution,1 yet it was not until the late 20th century that 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine–associated parkinsonism prompted investigations of occupational chemical exposures and disease.2 Since then, occupations such as farming, teaching, and welding have been proposed to increase risk of Parkinson disease (PD), but associations have been inconsistent.3-7 Few investigations have evaluated a direct relationship between occupational chemical exposures and PD. Toxicant-induced parkinsonism may have atypical features,8-9 but this factor has not been investigated systematically.
To address these concerns, we examined risk of parkinsonism in occupations (agriculture, education, health care, welding, and mining) and toxicant exposures (solvents and pesticides) putatively associated with PD. To minimize exposure misclassification, we used lifelong job task–specific occupational histories. To avoid overly restrictive diagnostic criteria that might exclude toxicant-induced cases, we enrolled subjects with typical or atypical parkinsonism. Detailed clinical characterization of cases was performed by movement disorders specialists (C.M.T., G.W.R., R.A.H., J.J., S.A.F., S.B., A.D., C.M., K.E.L., and J.W.L.). Multicenter case and control ascertainment was used to avoid geographic bias.
METHODS
RECRUITMENT
Cases
Enrolling investigators (C.M.T., G.W.R., R.A.H., J.J., S.A.F., S.B., C.M., and K.E.L.) at 8 North American movement disorders centers recruited consecutively eligible subjects between July 1, 2004, and May 31, 2007 (Table 1); they evaluated diagnostic features for parkinsonism,10-11 age at diagnosis, cognitive status, response to therapy, and Unified Parkinson Disease Rating Scale scores. At 2 centers, staff shortages limited strictly consecutive enrollment. Inclusion criteria were the following: (1) parkinsonism of no known cause, defined as 2 or more signs (resting tremor, bradykinesia, rigidity, and postural reflex impairment), 1 of which must be resting tremor or bradykinesia; (2) diagnosis within 8 years to minimize the risk of survival bias; and (3) absence of dementia.12
|
|
|
|
Table 1. Study Enrollment by Site
|
|
|
Control Subjects
Controls were frequency matched to cases by age, sex, and location. Persons with neurodegenerative disorders were excluded. To minimize bias related to demographic or socioeconomic differences, controls were primarily identified from (1) nonblood relatives (excluding spouses) or acquaintances of cases enrolled in the study or (2) nonblood relatives or acquaintances of other patients with parkinsonism in the movement disorders clinics. To minimize overmatching, workmates were ineligible as controls. Additional controls were recruited by the use of a commercial list of telephone numbers (A. Caldwell List Company, Inc, Norcross, Georgia) for men aged 50 to 65 years with zip codes matching those of enrolled cases.
Subjects were informed that the study objective was to investigate putative environmental risk factors for parkinsonism, without indicating specific hypotheses. Subjects were screened using the Telephone Interview for Cognitive Status.13
HUMAN SUBJECTS/RISK FACTOR INTERVIEWS
Human subject committees at each site approved the protocol. All subjects provided written informed consent. Interviewers at The Parkinson's Institute, Sunnyvale, California, used standardized computer-assisted telephone interviews to collect lifelong histories of tobacco, caffeine, and alcohol use and history of head injury and occupational histories (all jobs held for 3 months). For each job, information about the industry, location, processes, materials, and job tasks was collected.14 To determine toxicant exposure, detailed information was collected for the following job tasks: cleaning and degreasing, gluing, machining, painting, using pesticides, soldering, stripping paint, welding, and woodworking. Specific occupations (agriculture, education, health care, mining, and welding) and toxicant exposures (solvents and pesticides) were identified a priori as putative risk factors for parkinsonism based on mechanistic theories or information from prior publications.3-5,8-9,15-18
DEFINITION OF EXPOSURE VARIABLES
Analysis was limited to exposures before the reference age (age at diagnosis for cases and median age at diagnosis for cases in the appropriate sex and birth year–specific stratum for controls). Exposure variables were defined categorically and cumulatively. Tobacco, caffeine, and alcohol use for at least 6 months was defined as regular use. Cumulative exposure was defined as quantity over time using pack-years for cigarettes (1 pack of cigarettes per day for 1 year), milligram-years for caffeine (1 mg/d for 1 year), and drink-years for alcohol (1 alcoholic drink/d for 1 year). Head injury was defined as injury with loss of consciousness or as a physician-diagnosed concussion. Each occupation held before the reference date was classified by the use of the 2000 Standard Occupational Classification (SOC) Manual.19 Coders were unaware of case status. The SOC codes, specific job tasks, and occupational exposures were classified categorically and for duration of time worked before the reference date. The a priori hypotheses were represented by SOC 25-0000 (education), 29-0000 and 31-0000 (health care), and 45-0000 (farming), any welding or mining task and occupational exposure to solvents or pesticides.
DEFINITION OF CLINICAL FEATURES
Diagnosis and type of parkinsonism, Unified Parkinson Disease Rating Scale score, and clinical features were determined by the enrolling investigator. The postural instability and gait difficulty (PIGD) subtype was defined by the use of an established method.20
SAMPLE SIZE
Lifetime frequencies of the a priori–specified occupations and tasks of interest were estimated to range from 1% to 33% based on published studies4, 21-22 and on our unpublished control data from 2003 (C.M.T. et al). With an odds ratio (OR) of 3.5 and an exposure frequency of 1% or with an OR of 1.5 and an exposure frequency of 20%, 500 cases and 500 controls would be needed to have an 80% power to identify an association between the exposure and parkinsonism at a 2-sided 5% level of significance.
STATISTICAL ANALYSIS
Our primary occupational analysis determined risk of parkinsonism associated with categorical and cumulative work in the a priori–specified occupations, job tasks, or exposures. Secondary analyses included association of other major and minor occupational codes and parkinsonism. Additional analyses determined risk in subgroups (PD, atypical parkinsonism, the PIGD clinical subtype, or early age [ 50 years] at diagnosis) compared with controls. The Wilcoxon rank sum test was used for continuous variables and the Fisher exact test for categorical variables. Crude and adjusted ORs were calculated by the use of logistic regression models. Multiple logistic regression analysis was also used to obtain ORs adjusting for age (continuous), sex, race/ethnicity (white vs nonwhite), smoking (cigarette pack-years), caffeine use (milligram-years), alcohol use (drink-years), head injury (ever vs never), and duration of job or task (4 groups [never and tertiles of duration]). Site was modeled as a random effect, as was its interaction with an occupation, a job task, or an exposure. All analyses were performed by the use of commercially available software (SAS version 9.1.3 [SAS Institute, Cary, North Carolina]23 and SPSS version 12.01 [SPSS Inc, Chicago, Illinois]24).
RESULTS
Ninety-one percent of enrolled cases (519 of 571) and controls (511 of 561) were included in the primary analysis (Figure). Cases not analyzed were similar to those included, but controls not analyzed had a slightly lower educational level (<12 years of education in 36.0% not analyzed vs in 18.0% analyzed). About 90% of cases and 85% of controls were recruited from 5 sites (Table 1). The cases and controls were similar overall and among individual sites, except that controls recruited by telephone were mostly men aged 50 to 65 years. Subjects were primarily white males (Table 2); 96.9% had PD.
|
|
|
|
Figure. Study enrollment. * Indicates that reasons for ineligibility of cases and controls included severe hearing impairment, non–English speaking, and dementia.
|
|
|
|
|
|
|
Table 2. Demographic and Clinical Characteristics of Study Subjectsa
|
|
|
NONOCCUPATIONAL RISK FACTORS
Ever smoking cigarettes and number of pack-years smoked were inversely associated with risk of parkinsonism (Table 3). Ever drinking coffee and cumulative caffeine intake showed an inverse association of borderline statistical significance. Head injury was directly associated with PD risk, but the confidence intervals (CIs) were broad.
|
|
|
|
Table 3. Nonoccupational Risk Factorsa
|
|
|
STANDARDIZED OCCUPATIONAL CODES
All 23 major occupational codes, 92 of 99 minor codes, and 838 of 1600 unique 6-digit SOC codes were assigned at least once to cases and controls (mean, 9.5 codes for cases and 9.9 codes for controls) (Table 4). None of the a priori–identified occupational categories were associated with parkinsonism. Among the remaining major SOC categories, ever working in a legal or construction/extraction occupation was directly associated with parkinsonism. Among 92 minor SOC categories, ever working as a lawyer or judge (OR, 3.15; 95% CI, 1.3-7.6; P = .01 for SOC 23-1000) or as a religious worker (2.4; 1.04-5.52; P = .04 for SOC 21-2000) was associated with greater risk of parkinsonism, while lower risk was noted for personal care and service workers (0.58; 0.35-0.95; P = .03 for SOC 39-9000), food preparation workers (0.54; 0.36-0.82; P = .003 for SOC 35-2000), and military tactical weapons specialists (0.43; 0.28-0.65; P < .001 for SOC 55-3000). When these SOC code comparisons were adjusted for duration of work, associations were not maintained, and analyses repeated among PD cases did not change findings significantly.
|
|
|
|
Table 4. Odds Ratios for Parkinsonism and Association With Major Occupational Code Groups From the Standard Occupational Classification (SOC) Manual19 and Selected Job Tasks
|
|
|
SPECIFIC JOB TASKS AND EXPOSURES
Neither welding (any specific type) nor use of solvents (including carbon tetrachloride and trichloroethylene) increased risk of parkinsonism (Table 4 and Table 5). Ever painting, soldering, machining, using glue or adhesives, woodworking, and stripping wood or paint also did not differ between cases and controls. No individual type of glue or paint was associated with parkinsonism. No subjects had worked as miners. Of 144 subjects who did farm work, only 48 (33.3%) endorsed pesticide use. Among those farmers who did not use pesticides, 54.0% had stopped farming before age 20 years. Of 71 pesticide users, 51 (71.8%) were farmers, 18 (25.4%) worked in building and grounds maintenance, and 2 (2.8%) were soldiers. Cases were more likely to have ever used pesticides. Cases were also more likely to have ever used any of the 8 pesticides selected a priori as being of particular interest and to have ever used 2,4-dichlorophenoxyacetic acid. Paraquat and permethrin were rarely used, but association with greater risk of parkinsonism was suggested. Duration of any of the job tasks or exposures did not differ between cases and controls.
|
|
|
|
Table 5. Pesticide Use and Risk of Parkinsonism
|
|
|
ASSOCIATION WITH CLINICAL FEATURES
None of the occupations, job tasks, or task-associated exposures were associated with atypical parkinsonism or with younger age at diagnosis ( 50 years). Ever working in business and finance, legal occupations, construction and extraction, or transportation and material moving was associated with PIGD subtype but not after adjustment for duration.
COMMENT
Occupational use of pesticides was associated with an almost 80% greater risk of parkinsonism. Growing evidence suggests a causal association between pesticide use and parkinsonism.15, 17, 21, 25-28 However, the term "pesticide" is broad and includes chemicals with varied mechanisms. Because few investigations have identified specific pesticides, we studied 8 pesticides with high neurotoxic plausibility based on laboratory findings.29 Use of these pesticides was associated with higher risk of parkinsonism, more than double that in those not exposed.
Three individual compounds, the organochlorine 2,4-dichlorophenoxyacetic acid, the herbicide paraquat, and the insecticide and acaricide permethrin, were associated with more than a 3-fold increased risk of disease, although precision was poor for paraquat and permethrin. Combined exposure was observed in 44.8% of subjects (Table 5). To our knowledge, this is the first documented association of 2,4-dichlorophenoxyacetic acid with PD risk. Other organochlorines have been associated with increased risk of PD, and excessive amounts of organochlorines have been found in PD brains.22, 25, 30-31 Paraquat has also been associated with increased risk of PD.15, 21, 27-28 Paraquat32 and certain organochlorines33 are used to create experimental models of parkinsonism, which adds biologic plausibility to the hypothesis that pesticide exposure may be causal. Permethrin has not previously been associated with PD, to our knowledge. In mice, permethrin affects dopamine transport and may increase susceptibility of dopamine neurons to toxic insults.34-35 Permethrin-treated garments, tents, and netting are commonly used as antimalarial products in the military and in other settings.35 Many subjects may have long-term exposure. Additional assessment of permethrin as a risk factor for parkinsonism is warranted. Because exposure to more than 1 of these pesticides was common, future investigations should also assess the effects of combined exposure.
Longer duration of pesticide exposure has been associated with greater risk of parkinsonism in other populations.15 In our study, long-term pesticide use was uncommon. We found no association between exposure duration and disease risk. Other investigators have reported greater risk of parkinsonism among agricultural workers,3, 6, 15, 17, 36-38 but we found no association between the SOC code for agricultural work and parkinsonism, which confirms the suggestion that occupational code is a poor surrogate for pesticide use.39
Neither overall risk of parkinsonism or PD, age at diagnosis, nor PIGD subtype was associated with welding or machining in our study. This finding is in contrast to reports of elevated disease risk among subjects with occupational exposure to metals6, 22, 40 or among welders referred by attorneys41 and contradicts findings of earlier age at PD onset among welders.9 However, our results are in keeping with national databases, industrial populations, and clinic-based case-control studies,39, 42-47 which do not associate welding with greater risk of PD.
We did not replicate findings of prior studies3-4,43 associating education or health care work with greater risk of parkinsonism. Investigation of more specific SOC codes (eg, elementary school teacher) did not change these results. Another large case-control study39 that used occupational codes found no increased risk in these categories, while a smaller study43 found a higher risk among physicians. Methodologic considerations may have contributed to the associations found in other studies. The comparison of specialty clinic cases with census-derived controls may have introduced selection bias in one study.4 Another study5 reported the usual occupation of subjects from death records, while a third study3 compared tertiary clinic participants with published occupational statistics—which may overrepresent cases with higher educational level or socioeconomic status. Finally, occupational category is a surrogate for a disease-associated exposure; causal exposures may vary across populations.
We also systematically investigated job tasks and specific chemical exposures putatively associated with parkinsonism, with the inclusion of the solvent trichloroethylene.48 Apart from pesticides, no type of exposure was associated with disease risk.
Our secondary analyses explored associations of risk of parkinsonism with the major and minor SOC codes not of a priori interest. We found few associations between any SOC code and parkinsonism. The finding of greater parkinsonism risk associated with legal and religious work is not easily explained but is not unique to this study.3, 5-6 Because religious and legal workers in our control population were not underrepresented,49 these findings may not simply reflect selection bias. Only 1 of the SOC codes for which we found an association in these exploratory analyses—construction and extraction work—might carry a risk of chemical exposure. However, others4, 39, 43 found inverse associations between analogous codes and PD, suggesting that this result may be spurious. Several minor occupational codes were inversely associated with parkinsonism risk, including protective service supervisors, food preparation workers, and certain personal care or service workers; these associations were not seen after adjustment for duration of time worked. Only 2 other studies3, 50 reported decreased PD risk among service occupations. Whether this lower risk is owing to reduced toxicant exposure, the greater physical demands of these occupations (a healthy worker effect), or a spurious finding requires further study.
The PIGD subtype shares clinical features with toxicant-induced parkinsonism,18, 42, 47 yet neither job task nor toxicant exposure increased the risk of the PIGD subtype. However, risk of PIGD subtype was increased in subjects who ever worked in business and finance, construction and extraction, and legal occupations. A biologic explanation for these associations remains elusive.
Ever use of tobacco and ever smoking of cigarettes were inversely associated with parkinsonism and PD. Control smokers consumed more cigarettes than case smokers. Cumulative caffeine intake was greater in controls but not significantly so. Risk of parkinsonism was slightly increased in association with head injury, but precision was poor. Alcohol use was unassociated with disease risk. Like findings have been observed in many studies16 and indirectly support the similarity of our subjects to other study populations.
This study has several advantages. To our knowledge, it is the only study in which all cases were characterized by movement disorders specialists, which assures confidence in diagnosis and clinical subtype. Subjects were recruited from throughout North America, which provides geographic heterogeneity and a broad range of occupations. We also included subjects with atypical parkinsonism, because toxicant-induced parkinsonism may have atypical features, and studies that use strict diagnostic criteria could exclude toxicant-induced cases. Finally, the detailed interview collected information on key modifying factors (eg, tobacco use) and lifetime occupational and chemical exposure history. While the number of exposures to any individual risk was lower than in a population selected by occupation, potentially reducing the power to investigate an association, key exposures were well within the range of 1% to 33% that we projected (eg, 28.2% of controls worked with solvents, 7.4% welded, and 5.3% used pesticides [Table 4]) and were in keeping with national frequencies. Moreover, pesticide use had a magnitude of association with parkinsonism similar to that of other investigations. Even for our secondary analyses, power to detect moderate ORs was 80% for most exposures.
There are several limitations. First, we identified subjects from referral centers. While this approach allowed for improved diagnosis and investigation of clinical subgroups, these results may not apply to populations with different characteristics. Most of our subjects were of non-Hispanic white race/ethnicity. None had dementia, so associations of exposures with parkinsonism dementia could not be tested. However, our population generally resembled other case-control populations in sex, age, and lifestyle characteristics. The established inverse association of tobacco use with parkinsonism was observed in our population. Because cases and controls had similar demographic and socioeconomic characteristics, any potential bias is likely nondifferential. Second, we did not have direct quantitative exposure measurements. Because lifelong environmental or biologic monitoring is unavailable, the use of detailed job task–based interviews to infer exposure profiles is a valid and reliable alternative.14, 51-53 Recall bias may affect information provided by subjects, particularly for well-known putative risk factors such as welding or pesticide exposure. To minimize this factor during recruitment, specific hypotheses were not mentioned, and interview questionnaires collected a complete life history of jobs and tasks. Third, as in all case-control studies, causal relationships cannot be assumed.54 Fourth, we investigated many associations; some findings may be chance associations. Rather than applying stringent corrections for multiple comparisons, we have chosen to report these associations to allow for further investigation.
Occupational pesticide exposure emerges as the most consistent etiologic association with parkinsonism. The 3 specific pesticides identified (2,4-dichlorophenoxyacetic acid, paraquat, and permethrin) all have effects on dopaminergic neurons in experimental settings. This convergence of epidemiologic and laboratory data from experimental models of PD lends credence to a causative role of certain pesticides in the neurodegenerative process. Other pesticide exposures such as hobby gardening, residential exposure, wearing treated garments, or dietary intake were not assessed. Because these exposures may affect many more subjects, future attention is warranted.
AUTHOR INFORMATION
Correspondence: Caroline M. Tanner, MD, PhD, The Parkinson's Institute, 675 Almanor Ave, Sunnyvale, CA 94085 (CTanner{at}thepi.org).
Accepted for Publication: April 15, 2009.
Author Contributions: Dr Tanner had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Study concept and design: Tanner, Ross, Jankovic, and Langston. Acquisition of data: Tanner, Ross, Jewell, Hauser, Jankovic, Factor, Bressman, Deligtisch, Marras, Lyons, and Roucoux. Analysis and interpretation of data: Tanner, Ross, Jewell, Hauser, Jankovic, Marras, Bhudhikanok, Roucoux, Meng, Abbott, and Langston. Drafting of the manuscript: Tanner, Jewell, and Roucoux. Critical revision of the manuscript for important intellectual content: Ross, Hauser, Jankovic, Factor, Bressman, Deligtisch, Marras, Lyons, Bhudhikanok, Meng, Abbott, and Langston. Statistical analysis: Abbott, Bhudhikanok, and Meng. Obtained funding: Tanner and Langston. Administrative, technical, and material support: Ross, Jewell, Factor, Bressman, and Roucoux. Study supervision: Tanner, Jewell, Bressman, and Roucoux.
Financial Disclosure: Dr Hauser has received fees for providing expert testimony in cases related to PD in welders.
Funding/Support: This study was supported by an unrestricted grant from a group of current and former manufacturers of welding consumables awarded to The Parkinson's Institute.
Role of the Sponsor: The study sponsors were not involved in the design, conduct, analysis, or reporting of this work. All compensation received by investigators for study-related services was paid through contract between The Parkinson's Institute and the investigators' institutions.
Additional Contributions: Freya Kamel, PhD, MPH, provided helpful comments on the manuscript. We thank the patients who participated in this study, as well as their families.
| Study Steering Committee
Members
Caroline M. Tanner, MD, PhD; G. Webster Ross, MD; Robert D. Abbott, PhD; and J. William Langston, MD.
Enrolling Institutions, Investigators, and Coordinators (Listed by Number of Subjects Contributed)
The Parkinson's Institute, Sunnyvale, CA: Caroline M. Tanner, MD, PhD; Diana F. Roucoux, MPH; Sauda Yerabati, MPH; and Amanda Smith, MPH. University of South Florida, Tampa: Robert A. Hauser, MD; Diana Delaney; Summer Carter Wolfrath, MSPH; Joanne Nemeth; and Terry Mclain. Baylor College of Medicine, Houston, TX: Joseph Jankovic, MD; Christine Hunter, RN; Lina Shinawi; and Karen R. Flores. Emory University School of Medicine, Atlanta, GA: Stewart A. Factor, DO; and Carol Ingram, RN. Beth Israel Medical Center, New York, NY: Susan Bressman, MD; Amanda Deligtisch, MD; Karyn Boyar, RNC, MS, FNP; and Abby Wolff. Toronto Western Hospital, Toronto, Ontario, Canada: Connie Marras, MD, PhD, FRCPC; and Manoj Enjati. University of Kansas Medical Center, Kansas City: Kelly E. Lyons, PhD; Carey Mack, RN, BSN; April Langhammer; and Tamara Gales, LPN. Veterans Affairs Pacific Islands Health Care System, Honolulu, HI: G. Webster Ross, MD; and Frances K. Wakashige.
The Parkinson's Institute Coordination, Interviewer, and Analytic Staff
Meng Lu, MPH; Kathleen Comyns, MPH; Monica Korell, MPH; Lori Sterling; Rene VanVeghten; Maribel Padua; Jennifer Wright; Brianna Allred; Leah Bushman; Milele Bynum; Cara Cage; Amanda Carroll; Michael Chang; Rachel Cook; Emmet Ferriter; Michael Franco; Kat Gorman; Michelle Kemp; Sarah Knutson; Sarah Lavoie; Erin Mills; Chi Nguyen; Polina Niedle; Jacqueline Pia; Ben Priestley; Valerie Sims; Jane Ann Soetmelk; Brian Song; Bibi Stang; Melanie Staver; and Allison Stover.
|
|
Author Affiliations: Department of Clinical Research, The Parkinson's Institute, Sunnyvale, California (Drs Tanner, Jewell, Bhudhikanok, and Langston and Mss Roucoux and Meng); Department of Research and Development, Veterans Affairs Pacific Islands Health Care System, Honolulu, Hawaii (Dr Ross); Department of Neurology, University of South Florida, Tampa, (Dr Hauser); Department of Neurology, Baylor College of Medicine, Houston, Texas (Dr Jankovic); Department of Neurology, Emory University School of Medicine, Atlanta, Georgia (Dr Factor); Department of Neurology, Beth Israel Medical Center, New York, New York (Drs Bressman and Deligtisch); Department of Neurology, Toronto Western Hospital, Toronto, Ontario, Canada (Dr Marras); Department of Neurology, University of Kansas Medical Center, Kansas City (Dr Lyons); and Department of Statistics, University of Virginia School of Medicine, Charlottesville (Dr Abbott).
REFERENCES
1. Parkinson J. An Essay on the Shaking Palsy. London, England: Sherwood, Neeley, & Jones; 1817.
2. Langston JW, Ballard P, Tetrud JW, Irwin I. Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science. 1983;219(4587):979-980.
FREE FULL TEXT
3. Goldman SM, Tanner CM, Olanow CW, Watts RL, Field RD, Langston JW. Occupation and parkinsonism in three movement disorders clinics. Neurology. 2005;65(9):1430-1435.
FREE FULL TEXT
4. Tsui JK, Calne DB, Wang Y, Schulzer M, Marion SA. Occupational risk factors in Parkinson's disease. Can J Public Health. 1999;90(5):334-337.
WEB OF SCIENCE
| PUBMED
5. Schulte PA, Burnett CA, Boeniger MF, Johnson J. Neurodegenerative diseases. Am J Public Health. 1996;86(9):1281-1288.
WEB OF SCIENCE
| PUBMED
6. Park RM, Schulte PA, Bowman JD; et al. Potential occupational risks for neurodegenerative diseases. Am J Ind Med. 2005;48(1):63-77.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
7. Coggon D, Inskip H, Winter P, Pannett B. Occupational Mortality by Cause of Death. London, England: Her Majesty's Stationery Office; 1995.8. Rajput AH, Uitti RJ, Stern W, Laverty W. Early onset Parkinson's disease in Saskatchewan: environmental considerations for etiology. Can J Neurol Sci. 1986;13(4):312-316.
WEB OF SCIENCE
| PUBMED
9. Racette BA, McGee-Minnich L, Moerlein SM, Mink JW, Videen TO, Perlmutter JS. Welding-related parkinsonism. Neurology. 2001;56(1):8-13.
FREE FULL TEXT
10. Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol. 1999;56(1):33-39.
FREE FULL TEXT
11. Hughes AJ, Daniel SE, Lees AJ. The clinical features of Parkinson's disease in 100 histologically proven cases. Adv Neurol. 1993;60:595-599.
PUBMED
12. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed, text rev. Washington, DC: American Psychiatric Association; 2000.13. Gallo JJ, Breitner JC. Alzheimer's disease in the NAS-NRC Registry of aging twin veterans, IV: performance characteristics of a two-stage telephone screening procedure for Alzheimer's dementia. Psychol Med. 1995;25(6):1211-1219.
WEB OF SCIENCE
| PUBMED
14. Stewart PA, Stewart WF, Heineman EF, Dosemeci M, Linet M, Inskip PD. A novel approach to data collection in a case-control study of cancer and occupational exposures. Int J Epidemiol. 1996;25(4):744-752.
FREE FULL TEXT
15. Kamel F, Tanner C, Umbach D; et al. Pesticide exposure and self-reported Parkinson's disease in the Agricultural Health Study. Am J Epidemiol. 2007;165(4):364-374.
FREE FULL TEXT
16. Tanner C. Parkinson's disease: environmental factors and PD. In: Schapira AHV, Lang AET, Fahn S, eds. Movement Disorders 4: Blue Books of Practical Neurology. Vol 34. Amsterdam, the Netherlands: Elsevier Science. In press.17. Priyadarshi A, Khuder SA, Schaub EA, Shrivastava S. A meta-analysis of Parkinson's disease and exposure to pesticides. Neurotoxicology. 2000;21(4):435-440.
WEB OF SCIENCE
| PUBMED
18. Tanner C. Occupational and environmental causes of parkinsonism. In: Shusterman D, Blanc P, eds. Occupational Medicine: State of the Art Reviews: "Unusual Occupational Diseases." Philadelphia, PA: Hanley & Belfus Inc; 1992:503-513.19. US Department of Commerce. Standard Occupational Classification Manual. Latham, MD: Bernan Press; 2000.20. Jankovic J, McDermott M, Carter J; et al, Parkinson Study Group. Variable expression of Parkinson's disease. Neurology. 1990;40(10):1529-1534.
FREE FULL TEXT
21. Hertzman C, Wiens M, Bowering D, Snow B, Calne D. Parkinson's disease: a case-control study of occupational and environmental risk factors. Am J Ind Med. 1990;17(3):349-355.
WEB OF SCIENCE
| PUBMED
22. Seidler A, Hellenbrand W, Robra BP; et al. Possible environmental, occupational, and other etiologic factors for Parkinson's disease: a case-control study in Germany. Neurology. 1996;46(5):1275-1284.
FREE FULL TEXT
23. SAS [computer program]. Version 9.1.3. Cary, NC: SAS Institute Inc; 2004.24. SPSS [computer program]. Version 12.01. Chicago, IL: SPSS Inc; 2003.25. Hancock DB, Martin ER, Mayhew GM; et al. Pesticide exposure and risk of Parkinson's disease: a family-based case-control study. BMC Neurol. 2008;8:6e.
FULL TEXT
| PUBMED
26. Ascherio A, Chen H, Weisskopf MG; et al. Pesticide exposure and risk for Parkinson's disease. Ann Neurol. 2006;60(2):197-203.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
27. Liou HH, Tsai MC, Chen CJ; et al. Environmental risk factors and Parkinson's disease: a case-control study in Taiwan. Neurology. 1997;48(6):1583-1588.
FREE FULL TEXT
28. Costello S, Cockburn M, Bronstein J, Zhang X, Ritz B. Parkinson's disease and residential exposure to maneb and paraquat from agricultural applications in the central valley of California. Am J Epidemiol. 2009;169(8):919-926.
FREE FULL TEXT
29. Costa LG, Giordano G, Guizzetti M, Vitalone A. Neurotoxicity of pesticides: a brief review. Front Biosci. 2008;13:1240-1249.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
30. Fleming L, Mann JB, Bean J, Briggle T, Sanchez-Ramos JR. Parkinson's disease and brain levels of organochlorine pesticides. Ann Neurol. 1994;36(1):100-103.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
31. Corrigan FM, Wienburg CL, Shore RF, Daniel SE, Mann D. Organochlorine insecticides in substantia nigra in Parkinson's disease. J Toxicol Environ Health A. 2000;59(4):229-234.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
32. McCormack AL, Atienza JG, Johnston LC, Andersen JK, Vu S, Di Monte DA. Role of oxidative stress in paraquat-induced dopaminergic cell degeneration. J Neurochem. 2005;93(4):1030-1037.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
33. Hatcher JM, Richardson JR, Guillot TS; et al. Dieldrin exposure induces oxidative damage in the mouse nigrostriatal dopamine system. Exp Neurol. 2007;204(2):619-630.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
34. Elwan MA, Richardson JR, Guillot TS, Caudle WM, Miller GW. Pyrethroid pesticide-induced alterations in dopamine transporter function. Toxicol Appl Pharmacol. 2006;211(3):188-197.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
35. Macedo PA, Peterson RK, Davis RS. Risk assessments for exposure of deployed military personnel to insecticides and personal protective measures used for disease-vector management. J Toxicol Environ Health A. 2007;70(20):1758-1771.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
36. Gorell JM, Peterson EL, Rybicki BA, Johnson CC. Multiple risk factors for Parkinson's disease. J Neurol Sci. 2004;217(2):169-174.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
37. Dick FD, De Palma G, Ahmadi A; et al, Geoparkinson Study Group. Environmental risk factors for Parkinson's disease and parkinsonism: the Geoparkinson Study. Occup Environ Med. 2007;64(10):666-672.
FREE FULL TEXT
38. Firestone JA, Smith-Weller T, Franklin G, Swanson P, Longstreth WT Jr, Checkoway H. Pesticides and risk of Parkinson disease. Arch Neurol. 2005;62(1):91-95.
FREE FULL TEXT
39. Dick S, Semple S, Dick F, Seaton A. Occupational titles as risk factors for Parkinson's disease. Occup Med (Lond). 2007;57(1):50-56.
FREE FULL TEXT
40. Gorell JM, Johnson CC, Rybicki BA; et al. Occupational exposures to metals as risk factors for Parkinson's disease. Neurology. 1997;48(3):650-658.
FREE FULL TEXT
41. Racette BA, Tabbal SD, Jennings D, Good L, Perlmutter JS, Evanoff B. Prevalence of parkinsonism and relationship to exposure in a large sample of Alabama welders. Neurology. 2005;64(2):230-235.
FREE FULL TEXT
42. Jankovic J. Searching for a relationship between manganese and welding and Parkinson's disease. Neurology. 2005;64(12):2021-2028.
FREE FULL TEXT
43. Frigerio R, Elbaz A, Sanft KR; et al. Education and occupations preceding Parkinson disease. Neurology. 2005;65(10):1575-1583.
FREE FULL TEXT
44. Fryzek JP, Hansen J, Cohen S; et al. A cohort study of Parkinson's disease and other neurodegenerative disorders in Danish welders. J Occup Environ Med. 2005;47(5):466-472.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
45. Park J, Yoo CI, Sim CS; et al. A retrospective cohort study of Parkinson's disease in Korean shipbuilders. Neurotoxicology. 2006;27(3):445-449.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
46. Fored CM, Fryzek JP, Brandt L; et al. Parkinson's disease and other basal ganglia or movement disorders in a large nationwide cohort of Swedish welders. Occup Environ Med. 2006;63(2):135-140.
FREE FULL TEXT
47. Santamaria AB, Cushing CA, Antonini JM, Finley BL, Mowat FS. State-of-the-science review: does manganese exposure during welding pose a neurological risk? J Toxicol Environ Health B Crit Rev. 2007;10(6):417-465.
WEB OF SCIENCE
| PUBMED
48. Gash DM, Rutland K, Hudson NL; et al. Trichloroethylene: parkinsonism and complex 1 mitochondrial neurotoxicity. Ann Neurol. 2008;63(2):184-192.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
49. US Bureau of Labor Statistics. National Occupational Employment and Wage Estimates. Washington, DC: Division of Occupational Employment Statistics, US Bureau of Labor Statistics; 2007.50. Kirkey KL, Johnson CC, Rybicki BA, Peterson EL, Kortsha GX, Gorell JM. Occupational categories at risk for Parkinson's disease. Am J Ind Med. 2001;39(6):564-571.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
51. Semple SE, Dick F, Cherrie JW, Geoparkinson Study Group. Exposure assessment for a population-based case-control study combining a job-exposure matrix with interview data. Scand J Work Environ Health. 2004;30(3):241-248.
WEB OF SCIENCE
| PUBMED
52. Teschke K, Olshan AF, Daniels JL; et al. Occupational exposure assessment in case-control studies: opportunities for improvement. Occup Environ Med. 2002;59(9):575-594.
FREE FULL TEXT
53. Hobson AJ, Sterling DA, Emo B; et al. Validity and reliability of an occupational exposure questionnaire for parkinsonism in welders. J Occup Environ Hyg. 2009;6(6):324-331.
FULL TEXT
|
WEB OF SCIENCE
| PUBMED
54. Rothman KJ. Causes. Am J Epidemiol. 1976;104(6):587-592.
FREE FULL TEXT
CiteULike Connotea Delicious Digg Facebook Reddit Technorati Twitter
What's this?
RELATED ARTICLE
This Month in Archives of Neurology
Arch Neurol. 2009;66(9):1056-1057.
FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Mortality from Parkinson's disease and other causes among a workforce manufacturing paraquat: a retrospective cohort study
Tomenson and Campbell
BMJ Open 2011;1:e000283-e000283.
ABSTRACT
| FULL TEXT
Mitochondrial dysfunction and loss of Parkinson's disease-linked proteins contribute to neurotoxicity of manganese-containing welding fumes
Sriram et al.
FASEB J. 2010;24:4989-5002.
ABSTRACT
| FULL TEXT
Persistent organochlorine pesticides in serum and risk of Parkinson disease
Weisskopf et al.
Neurology 2010;74:1055-1061.
ABSTRACT
| FULL TEXT
|